artesunic acid has been researched along with Experimental Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cheng, L; Du, Y; He, W; Li, X; Wang, J; Wang, T | 1 |
Cao, X; Gong, A; Qi, J; Wang, D; Wang, K; Wang, M; Zhang, Z; Zhu, H | 1 |
Das, P; Kumar, VL; Verma, S | 1 |
3 other study(ies) available for artesunic acid and Experimental Neoplasms
Article | Year |
---|---|
Dimeric Artesunate-Phosphatidylcholine-Based Liposomes for Irinotecan Delivery as a Combination Therapy Approach.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artesunate; Cell Line, Tumor; Drug Combinations; Drug Delivery Systems; Female; Irinotecan; Liposomes; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Phosphatidylcholines | 2021 |
Role of GRP78 inhibiting artesunate-induced ferroptosis in
Topics: Animals; Artesunate; Endoplasmic Reticulum Chaperone BiP; Female; Ferroptosis; Heat-Shock Proteins; Humans; Lipid Peroxidation; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Neoplasms, Experimental; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Tumor Cells, Cultured | 2019 |
Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer.
Topics: 1,2-Dimethylhydrazine; Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Artesunate; Aspirin; Colorectal Neoplasms; Cyclooxygenase 2; Down-Regulation; Drug Administration Schedule; Interleukin-1beta; Male; Neoplasms, Experimental; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Treatment Outcome | 2019 |